J&J | صافي الدخل



Net Income تغيير تاريخ
AbbVie USD 1.29B 1.31B 2025-03
Abbott USD 1.78B 454M 2025-06
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Baxter International USD 126M 638M 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Becton, Dickinson and Co. USD 308M 5M 2025-03
Biogen USD 240.5M 26.2M 2025-03
Boston Scientific USD 674M 108M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
CONMED USD 6.04M 27.72M 2025-03
Cooper Companies USD 87.7M 16.6M 2025-04
Dexcom USD 105.4M 46.3M 2025-03
Edwards Lifesciences USD 358M 27.6M 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Globus Medical USD 75.46M 48.96M 2025-03
Hologic USD -17400000 218.4M 2025-03
Indivior 48M 11M 2025-03
Insulet USD 35.4M 65.3M 2025-03
Integra LifeSciences USD -25293000 44.73M 2025-03
Intuitive Surgical USD 658.4M 40M 2025-06
J&J USD 5.54B 5.46B 2025-06
Medtronic USD 1.06B 237M 2025-04
Merck USD 5.08B 1.34B 2025-03
Merit Medical Systems USD 30.15M 2.2M 2025-03
Novartis USD 4.02B 418M 2025-06
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Stryker USD 654M 108M 2025-03
Tandem Diabetes Care USD -130556000 131.31M 2025-03
Teva Pharmaceutical Industries USD 214M 431M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12
Zoetis USD 631M 50M 2025-03


J&J صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.